Gene-Therapy

FDA clears Casgevy gene therapy for children as young as two with sickle cell disease 0 FDA reverses course on Regenxbio's gene therapy for Hunter syndrome 0 FDA reverses course, clears UniQure to file Huntington's gene therapy 0